GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » EBITDA Margin %

LSL Pharma Group (TSXV:LSL) EBITDA Margin % : 5.06% (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. LSL Pharma Group's EBITDA for the three months ended in Jun. 2024 was C$0.21 Mil. LSL Pharma Group's Revenue for the three months ended in Jun. 2024 was C$4.19 Mil. Therefore, LSL Pharma Group's EBITDA margin for the quarter that ended in Jun. 2024 was 5.06%.


LSL Pharma Group EBITDA Margin % Historical Data

The historical data trend for LSL Pharma Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group EBITDA Margin % Chart

LSL Pharma Group Annual Data
Trend Sep20 Dec21 Dec22 Dec23
EBITDA Margin %
20.55 10.63 -69.97 -57.57

LSL Pharma Group Quarterly Data
Sep20 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.78 -2.35 10.38 12.01 5.06

Competitive Comparison of LSL Pharma Group's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, LSL Pharma Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LSL Pharma Group's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, LSL Pharma Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where LSL Pharma Group's EBITDA Margin % falls into.



LSL Pharma Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

LSL Pharma Group's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-5.773/10.028
=-57.57 %

LSL Pharma Group's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=0.212/4.191
=5.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LSL Pharma Group  (TSXV:LSL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


LSL Pharma Group EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


LSL Pharma Group Business Description

Traded in Other Exchanges
N/A
Address
3030, Le Carrefour Boulevard, Suite 1002, Laval, QC, CAN, H7T 2P5
Website
LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group Headlines

No Headlines